Akhil Tripathi

Akhil Tripathi is a British entrepreneur and the co-founder and CEO of Signifier Medical Technologies, a pioneering company in the field of medical devices for sleep-disordered breathing. With a strong background in healthcare innovation, Tripathi is recognized for his work in developing eXciteOSA, a groundbreaking, non-invasive device that uses neuromuscular electrical stimulation to treat snoring and mild sleep apnea.

Under his leadership, Signifier Medical Technologies has achieved regulatory approvals across multiple key markets, including the UK, Europe, Canada, Australia, and is awaiting FDA approval in the United States. Tripathi's vision for the company is centered on providing patient-friendly, non-invasive solutions that address the root causes of sleep-related disorders, rather than merely managing symptoms. This focus has led the company to gain significant recognition within the medical technology industry.

Founded in 2015 with ENT surgeon Professor Anshul Sama, Signifier Medical Technologies was created out of a shared mission to improve patient outcomes through innovation. Their flagship product, eXciteOSA, has quickly gained traction as a comfortable and effective alternative to traditional CPAP machines, which are often seen as cumbersome and uncomfortable for users.

In addition to his work at Signifier, Tripathi is a trustee for the Get Ahead Charity, which supports head and neck cancer patients. Through both his professional and philanthropic endeavors, Tripathi continues to drive advancements in medical technology, pushing the boundaries of healthcare innovation to improve lives globally.